IOL Chemicals and Pharmaceuticals Ltd

NSE: IOLCP · BSE: 524164 · Pharmaceuticals & Biotechnology · 31 announcements

IOL Chemicals and Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹219.29
Market cap: ₹6,437 Cr
Revenue (annual): ₹2,319 Cr
Net profit (annual): ₹137.6 Cr
P/E (TTM): 38.3×Sector 47.4×
Promoter holding: 62.28%+4.80% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10 Aug 2026 14:16 IST BSE

IOL Chemicals and Pharmaceuticals Q1 FY27 Results: Net Profit ₹64.4 Cr, Up 90.0% YoY

IOL Chemicals and Pharmaceuticals Ltd reported revenue from operations of ₹756.3 Cr (+37.1% YoY) and net profit of ₹64.4 Cr (+90.0% YoY) for Q1 FY27.

Key figure: Net profit ₹64.4 Cr · +90.0% YoY

Open full results → Read the filing ↗

20 May 2026 14:32 IST NSE

Financial ResultsAlfa Alert

IOL Chemicals and Pharmaceuticals Q4 FY26 Results: Net Profit ₹53.2 Cr, Up 69.4% YoY

IOL Chemicals and Pharmaceuticals Ltd reported revenue from operations of ₹619.5 Cr (+17.4% YoY) and net profit of ₹53.2 Cr (+69.4% YoY) for Q4 FY26.

Key figure: Net profit ₹53.2 Cr · +69.4% YoY

Open full results → Read the filing ↗

20 May 2026 14:31 IST NSE

Financial Results

IOL Chemicals and Pharmaceuticals Financial Results

IOL Chemicals reported annual consolidated net profit of ₹137.64 Crore. The company also announced a ₹22.75 Crore capacity expansion for Triacetin and Pantoprazole products.

Value: ₹22.75 Cr

Read the filing ↗